fda pulling semaglutide U.S. finds no evidence yet linking weight-loss drugs to suicidal thoughts US judge upholds FDA's removal

Metformin, the medicine in Metformin tablets, can cause a rare, but serious, side effect called lactic acidosis (a build-up of lactic acid in the blood) that can cause death

The link between type 2 diabetes mellitus and the polymorphisms of glutathione-metabolizing genes suggests a new hypothesis explaining disease initiation and progression

Weight loss can also improve OSA in patients with obesity or overweight as seen with the FDA approval of tirzepatide (Zepbound) and in clinical trials of the investigational GLP-1 agent orforglipron

Sun Pharmaceutical Industries, Dr Reddy's Laboratories, Zydus Lifesciences, Lupin, and Mankind Pharma are expected to launch their generics version of semaglutide on Saturday (21), a day after the patent expires